Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Cell growth regulating factor P and its prepn process

A technology of cell growth regulation factors and genes, which is applied in the field of biomedicine, can solve limitations and other problems, and achieve the effect of enhancing TC, promoting the activation of the body, and enhancing immune function

Inactive Publication Date: 2007-07-04
谢旭明
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although people have a deeper understanding of various types of bacteria, they are only limited to the scope of understanding. There are many deficiencies in medical research on how to use bacteria to treat and prevent diseases, leaving many medical gaps.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Example 1, Gram-positive cocci were first screened and frozen to preserve the strains, and the strains were routinely cultured at 6°C. Generally, the lower the temperature, the longer the culture time. After the strains were fully cultivated, they were filtered four times to remove impurities and The fragments of beneficial bacteria left behind the harmful bacteria are the extraction of natural genes. Since Gram coccus is a common disease-carrying strain in clinical medicine, the public can obtain it from the public, so this strain does not need to be specially preserved. After being fully cultivated and filtered, the purpose of removing pathogenic bacteria can be achieved. Take 1 μg of beneficial bacteria fragments, that is, natural genes, add 1 mg of aspartic acid quantitatively to it, measure the content and pass the safety test, and seal it under the GMP standard. After the finished product passes the inspection, it is printed and packaged. The said aspartic acid is...

Embodiment 2

[0015] Example 2: Gram-negative cocci were first screened and the strains were frozen and preserved, and the strains were routinely cultured at a temperature of 12°C. After the strains were fully cultured, they were filtered three times successively to remove impurities and harmful bacteria, leaving beneficial bacteria fragments , which is to extract natural genes; take 1 μg of beneficial bacteria fragments, that is, natural genes, add 3 mg of aspartic acid quantitatively to it, measure the content, and after safety testing, seal the water under the GMP standard to form the natural cell growth regulator P , After the finished product passes the inspection, it will be printed and packaged.

Embodiment 3

[0016] Example 3, the Gram-negative bacilli were first screened and the strains were frozen and preserved, and the strains were conventionally cultured at a temperature of 20°C. After the strains were fully cultivated, they were filtered twice successively to remove impurities and harmful bacteria, leaving beneficial bacteria Fragments are the extraction of natural genes; take 1 μg of beneficial bacteria fragments, that is, natural genes, add 8 mg of aspartic acid quantitatively to them, measure the content, and after safety testing, seal them in GMP standard water or freeze-dried powder to form natural cells The growth regulating factor P is printed and packaged after the finished product passes the inspection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is natural cell regulating factor P and its preparation process. It is prepared through screening Gram-positive coccus, Gram-negative coccus or bacillus, freezing preservation of strain, conventional culture of the strain at 4-38 deg.c, filtering to filter out harmful thallus while leafing beneficial thallus or extracting natural gene, adding aspartic acid into the natural gene, safety inspection and forming into oral liquid or freeze dried powder. The natural cell regulating factor P product has aspartic acid content the same as that of natural cell regulating factor P. It has the functions of activating and strengthening immune, strengthening TC, repairing and regenerating cell tissue, vessel and epithelium, etc.

Description

technical field [0001] The invention relates to a medicine beneficial to the growth regulation of biological cells and a preparation method thereof, belonging to a kind of biological medicine. Background technique [0002] Birth, old age, sickness and death are a natural law for human beings. With the aging of human cells, the regenerative function of the cells will gradually lose. The human body enters the aging period, and various cells in the human body decline. For example, the recovery of the elderly is much slower than that of the young. A lot is a good proof. Human aging is mainly manifested in cell aging and functional decline of various internal organs. Therefore, in recent years, medical experts from all over the world are trying to study "longevity medicine" to prolong human life. The so-called longevity medicine is nothing more than that this kind of medicine can promote the regeneration of human cells and the enhancement and improvement of repair ability. Howe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7088A61P37/04A61P17/00A61P9/00A61P43/00
Inventor 谢旭明谢黎升黎景黎智谢昱青朱红
Owner 谢旭明
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com